NVNO enVVeno Medical: חובות לטווח קצר של החברה

Financial debt with a maturity of up to 12 months illustrates the implementation of robotic laser welding to create perfect venous valves for enVVeno Medical (NVNO). Stable management is confidently conducting clinical tests of the prostheses while optimizing costs. However, geopolitical logistics disruptions and sanctions are slowing the expansion of these innovations. The value of 0.00 determines the latest valuation metric for the operating liquidity and debt load of enVVeno Medical (NVNO).

To develop the innovative VenoValve prosthesis, enVVeno Medical (NVNO) requires stable funding for operating cycles and short-term liquid reserves. This indicator aggregates all liabilities with a maturity of up to one year, allowing for an assessment of working capital deficit risk through the volatility of short-term debt and determining the issuer's actual ability to service current debts without raising emergency capital.